Dental OSCE 2025 – 400 Free Practice Questions to Pass the Exam

Epinephrine is a potent sympathomimetic agent that can stimulate both alpha and beta-adrenergic receptors, leading to increased heart rate, enhanced myocardial contractility, and peripheral vasoconstriction. These effects can be particularly concerning in patients with hyperthyroid conditions.

In hyperthyroidism, the body's metabolic state is already heightened, often resulting in increased sensitivity to catecholamines like epinephrine. This can exacerbate symptoms such as tachycardia, hypertension, and even precipitate a thyroid storm, a life-threatening escalation of hyperthyroidism that can occur in response to stressors.

Given these potential complications, the use of epinephrine is contraindicated in patients with hyperthyroidism to avoid overstimulation of the cardiovascular system and to manage the risk of serious adverse events.

While cardiovascular disease may also raise concerns regarding the use of epinephrine due to its potential to exacerbate conditions like arrhythmias or heart failure, hyperthyroidism poses unique risks that make it particularly crucial to avoid epinephrine in these patients. Understanding the intricate relationship between hyperthyroid states and adrenergic medications can aid in ensuring safe and effective patient management.